Application of Metal-Organic Framework in Diagnosis and Treatment of Diabetes

Biomolecules. 2022 Sep 5;12(9):1240. doi: 10.3390/biom12091240.

Abstract

Diabetes-related chronic wounds are often accompanied by a poor wound-healing environment such as high glucose, recurrent infections, and inflammation, and standard wound treatments are fairly limited in their ability to heal these wounds. Metal-organic frameworks (MOFs) have been developed to improve therapeutic outcomes due to their ease of engineering, surface functionalization, and therapeutic properties. In this review, we summarize the different synthesis methods of MOFs and conduct a comprehensive review of the latest research progress of MOFs in the treatment of diabetes and its wounds. State-of-the-art in vivo oral hypoglycemic strategies and the in vitro diagnosis of diabetes are enumerated and different antimicrobial strategies (including physical contact, oxidative stress, photothermal, and related ions or ligands) and provascular strategies for the treatment of diabetic wounds are compared. It focuses on the connections and differences between different applications of MOFs as well as possible directions for improvement. Finally, the potential toxicity of MOFs is also an issue that we cannot ignore.

Keywords: biological materials; diabetes; diagnosis of diabetes; metal–organic framework; sensors; skin regeneration; synthetic; wound healing.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Infective Agents*
  • Diabetes Mellitus* / diagnosis
  • Diabetes Mellitus* / therapy
  • Glucose
  • Humans
  • Hypoglycemic Agents
  • Ions
  • Metal-Organic Frameworks* / therapeutic use

Substances

  • Anti-Infective Agents
  • Hypoglycemic Agents
  • Ions
  • Metal-Organic Frameworks
  • Glucose

Grants and funding

We acknowledge funding support by joint funding from the Department of Science and Technology of Shaanxi Province and Northwestern Polytechnical University (No. 2020GXLH-Z-021) and the National Natural Science Foundation of China (Grant No. 51801158).